Chicago Partners Investment Group’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.8K | Sell |
10,887
-1,844
| -14% | -$3.85K | ﹤0.01% | 1089 |
|
|
2025
Q1 | $6.82K | Buy |
+12,731
| New | +$6.82K | ﹤0.01% | 932 |
|
|
2024
Q4 | – | Sell |
-13,593
| Closed | -$9.55K | – | 875 |
|
|
2024
Q3 | $9.55K | Sell |
13,593
-2,880
| -17% | -$2.02K | ﹤0.01% | 795 |
|
|
2024
Q2 | $15.2K | Sell |
16,473
-1,581
| -9% | -$1.46K | ﹤0.01% | 743 |
|
|
2024
Q1 | $33.9K | Buy |
18,054
+734
| +4% | +$1.38K | ﹤0.01% | 727 |
|
|
2023
Q4 | $40.5K | Sell |
17,320
-676
| -4% | -$1.58K | ﹤0.01% | 687 |
|
|
2023
Q3 | $37.4K | Sell |
17,996
-7,069
| -28% | -$14.7K | ﹤0.01% | 645 |
|
|
2023
Q2 | $74.7K | Sell |
25,065
-2,286
| -8% | -$6.81K | ﹤0.01% | 664 |
|
|
2023
Q1 | $126K | Buy |
27,351
+16,440
| +151% | +$75.5K | 0.01% | 638 |
|
|
2022
Q4 | $62.8K | Sell |
10,911
-3,638
| -25% | -$21K | ﹤0.01% | 624 |
|
|
2022
Q3 | $66K | Buy |
14,549
+1,659
| +13% | +$7.53K | ﹤0.01% | 572 |
|
|
2022
Q2 | $59K | Buy |
12,890
+26
| +0.2% | +$119 | ﹤0.01% | 579 |
|
|
2022
Q1 | $54K | Sell |
12,864
-1,812
| -12% | -$7.61K | ﹤0.01% | 551 |
|
|
2021
Q4 | $121K | Sell |
14,676
-4,192
| -22% | -$34.6K | 0.01% | 543 |
|
|
2021
Q3 | $316K | Sell |
18,868
-11,918
| -39% | -$200K | 0.02% | 427 |
|
|
2021
Q2 | $398K | Buy |
+30,786
| New | +$398K | 0.03% | 364 |
|